This clinical trial is focused on studying the effects of using oxygen as a treatment for patients with acute pulmonary embolism. Acute pulmonary embolism is a condition where one or more arteries in the lungs become blocked by a blood clot. The trial aims to determine how effective supplemental oxygen is for patients who are at intermediate risk due to this condition.
The study will involve patients who have been diagnosed with acute pulmonary embolism and will assess the role of oxygen over a period of 30 days. Participants will receive oxygen through inhalation, which means breathing in the oxygen gas. The trial will compare the outcomes of those receiving oxygen with those who do not, to see if oxygen helps improve their condition.
The main goal of the study is to evaluate whether using oxygen can prevent serious complications such as hemodynamic collapse, which is a severe drop in blood pressure, or death within 30 days. The study will also look at other factors like the length of hospital stay and any serious side effects. The results will help understand if oxygen is beneficial for patients with acute pulmonary embolism.
Italy 
Spain 
